Myelodysplastic Phase During a Complete Course of Polycythemia Vera: Confirming Azacytidine Effectiveness on Myelodysplastic but not on Myeloproliferative Clone
Gianmario Pasqualone1, Marcello Roberto1, Vincenzo Fraticelli2, Maria Pia Petrilli2, Cristiana Gasbarrino2, Gianfranco Giglio3, Vincenzo Martinelli1,4* and Sergio Storti5
1Department of Medicine and Health Sciences “Vincenzo Tiberio”, University of Molise, Campobasso, Italy
2Hematologist, Oncohematology Department, Gemelli Molise SpA, Campobasso, Italy
3Hematologist, Oncology Operating Unit, “Antonio Cardarelli” Hospital, Azienda Sanitaria Regionale del Molise (ASReM), Campobasso, Italy
4Department of Medicine and Surgery, Haematopoietic Stem Cell Transplant Center; University of Naples Federico II, Naples, Italy
5Catholic University of the Sacred Heart, Agostino Gemelli Hospital, Rome, Italy
*Corresponding author: Vincenzo Martinelli, Department of Medicine and Health Sciences, University of Molise – Contrada Tappino, 86100 Campobasso (CB); Department of Medicine and Surgery, University of Naples Federico II – Via Sergio Pasini, 5 – 80131 Napoli (NA), Italy, Tel: +390817464392; E-mail: vincenzo.martinelli@unimol.it
Author’s Contributions: Pasqualone G and Roberto M contributed equally to this case report.
Received: March 22, 2021; Accepted: March 28, 2021; Published: April 11, 2021
Citation: Pasqualone G, Roberto M, Fraticelli V, et al. Myelodysplastic Phase During a Complete Course of Polycythemia Vera: Confirming Azacytidine Effectiveness on Myelodysplastic but not on Myeloproliferative Clone. Clin Image Case Rep J. 2021; 3(3): 153.
Comments
Post a Comment